Amneal Pharmaceuticals Inc AMRX:NYSE

RT Quote | NYSE | USD
Last | 09/28/22 EDT
2.06quote price arrow up+0.02 (+0.98%)
Volume
653,650
52 week range
2.00 - 5.99
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.06
  • 52 Week High5.99
  • 52 Week High Date10/12/21
  • 52 Week Low2.00
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap625.27M
  • Shares Out303.53M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-56.99

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.06
  • 52 Week High5.99
  • 52 Week High Date10/12/21
  • 52 Week Low2.00
  • 52 Week Low Date09/23/22
  • Market Cap625.27M
  • Shares Out303.53M
  • 10 Day Average Volume1.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-56.99

RATIOS/PROFITABILITY

  • EPS (TTM)-0.88
  • P/E (TTM)-2.34
  • Fwd P/E (NTM)2.81
  • EBITDA (TTM)412.939M
  • ROE (TTM)-42.65%
  • Revenue (TTM)2.122B
  • Gross Margin (TTM)36.18%
  • Net Margin (TTM)-12.87%
  • Debt To Equity (MRQ)1,012.94%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amneal Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Amneal Pharmaceuticals, Inc. is a pharmaceutical company. The Company specializes in developing, manufacturing, marketing and distributing generic and branded specialty pharmaceutical products. It operates through three segments: Generics, Specialty, and AvKARE. Its Generics segment includes approximately 250 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables...
Paul Meister
Independent Chairman of the Board
Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
Anastasios Konidaris
Chief Financial Officer, Executive Vice President
Andrew Boyer
Executive Vice President, Chief Commercial Officer - Generics
Gustavo Pesquin
Executive Vice President, Chief Commercial Officer - Speciality
Address
400 Crossing Blvd Fl 3
Bridgewater, NJ
08807-2863
United States

Top Peers

SYMBOLLASTCHG%CHG
EBS
Emergent BioSolutions Inc
21.33+0.80+3.90%
ENDPQ
Endo International PLC
0.1052UNCHUNCH
PAHC
Phibro Animal Health Corp
13.11+0.29+2.26%
AMRN
Amarin Corporation PLC
1.19+0.06+5.31%
PBH
Prestige Consumer Healthcare Inc
49.98+1.26+2.59%